Lipocine Inc. (LPCN)
NASDAQ·Healthcare·Biotechnology
$2.17
+0.27%
Mkt Cap $43.75M
Analyst Ratings
Buy
0
Hold
1
Sell
0
Price Target (3 analysts)
$6.00
Range $6.00 – $6.00
Implied Upside
+177.0%
Consensus $6.00 vs current $2.17
NASDAQ·Healthcare·Biotechnology
$2.17
+0.27%
Mkt Cap $43.75M
Buy
0
Hold
1
Sell
0
Price Target (3 analysts)
$6.00
Range $6.00 – $6.00
+177.0%
Consensus $6.00 vs current $2.17